Hormone Replacement Therapy (HRT) Market 2023 Trends Analysis by Product, Route of Administration, Disease Type, Region, and Leading Players Novartis AG, Abbott Laboratories

The global Hormone Replacement Therapy (HRT) Market size is projected to reach a CAGR of 6.3% from 2023-2030. Hormone Replacement Therapy (HRT) Market, By Product (Estrogen & Progesterone Replacement Therapy), By Route of Administration, By Disease Type and Region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).

Request For Free Sample Report: https://www.delvens.com/get-free-sample/hormone-replacement-therapy-hrt-market-trends-forecast-till-2030

Hormone Replacement Therapy (HRT) Market Competitive Landscape:

Novartis AG
Abbott Laboratories
Mylan N.V.
Merck KgaA
Bayer AG
Pfizer Inc.
Novo Nordisk A/S
QuatRx Pharmaceuticals
Teva Pharmaceutical Industries Ltd.
Amgen, Inc.
Eli Lilly and Company

May 2021 - Myovant Sciences GmbH announced that it received approval from the U.S. FDA for its hormone therapy Myfembree as a treatment for uterine fibroid bleeding. The drug launched by Myovant will give direct competition to AbbVie with an added dosing advantage.

April 2021 - TherapeuticsMD, Inc. and Theramex announced that they received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) and Federal Agency of Medicines and Health Products (FAMHP) for the use of BIJUVE in the U.K and under BIJUVA trade name in Belgium. The capsule will be used as hormone replacement therapy.

The increasing prevalence of chronic conditions such as hypogonadism in adult men worldwide is expected to drive the growth of the hormone replacement therapy market. Furthermore, another major factor fuelling the growth of the market is the ease of access to hormonal replacement therapy and government support for research and development activities for hormonal replacement therapy drugs.

On the other hand, stringent regulations proposed by the regulatory authorities regarding the application of hormone replacement products, owing to the increased risk of adverse cardiovascular diseases and the high cost associated with the replacement therapy are the major factors restraining the growth of the market.

The impact of COVID-19 on the hormone replacement market has been negative due to the widespread shortage of these therapies' supplies across the globe. The shortage has further led to the distress of pre-and post-menopausal women globally. Due to the COVID-19 pandemic, the difficulty of the manufacturers in procuring raw materials is one of the reasons leading to the scarcity of these products. Furthermore, the pandemic has led to a negative impact on the sales of these products across the globe due to the closure of healthcare facilities, such as hospitals and clinics, in the initial days of the pandemic. These closures have led to a significant negative impact on the diagnosis of patients suffering from hormonal disorders.

Make an Inquiry Before Buying: https://www.delvens.com/Inquire-before-buying/hormone-replacement-therapy-hrt-market-trends-forecast-till-2030

Hormone Replacement Therapy (HRT) Market Key Findings

The product segment is further fragmented into Estrogen and Progesterone Replacement Therapy, Human Growth Hormone (HGH) Replacement Therapy, Thyroid Hormone Replacement Therapy, Testosterone Replacement Therapy, and Parathyroid Hormone Replacement. The estrogen and progesterone replacement therapy segment held the highest market. The dominance was attributed due to an increase in the number of women suffering from menopause.

The route of administration segment is further fragmented into Oral, Parenteral, Transdermal, and Others. The oral segment dominated the market due to the high prescription rate and ease of administration. Most HRT products generally include pills & tablets.

The disease segment is further fragmented into Menopause, Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, and Hypoparathyroidism. The menopause segment dominated the market and is anticipated to maintain its dominance during the forecast period. This can be attributed to the owing to increase in the number of women suffering from menopause.

The market is also divided into various regions such as North America, Europe, Asia-Pacific, South America, and Middle East and Africa. North America dominated the global hormone replacement therapy market and is anticipated to grow at a significant rate during the forecast period. Major product launches, collaborative agreements between manufacturers, and favorable reimbursement policies are among the factors responsible for the largest market share in the region.

North America to Dominate the Market

North America dominated the global hormone replacement therapy market and is anticipated to grow at a significant rate during the forecast period.

Major product launches, collaborative agreements between manufacturers, and favorable reimbursement policies are among the factors responsible for the largest market share in the region.

Delvens Industry Expert's Standpoint

One big area of the pharmaceutical business that is anticipated to increase over the next several years is the market for hormone replacement treatment. The prevalence of menopause is increasing, and this development is fueled by factors including growing public knowledge of the advantages of HRT. The availability of alternative therapies and worries about the security and efficacy of HRT provide further obstacles for the industry. Despite these obstacles, the largest HRT market players are spending on research and development to produce cutting-edge solutions that satisfy patients' changing demands. Companies will need to keep up with market trends and developments as well as any changes in those trends and developments in order to remain competitive.

Direct Purchase of Hormone Replacement Therapy (HRT) Market Research Report at: https://www.delvens.com/checkout/hormone-replacement-therapy-hrt-market-trends-forecast-till-2030

Contact Us:

UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-8638-5055
SALES@DELVENS.COM
WEBSITE: https://delvens.com/

About Us:

Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.

Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.

This release was published on openPR.